Author: admin

Pure Parima Expands Best-Selling Ultra Percale Collection with Two New Colors: Flax & Salt

The Coveted Hotel Collection is Fully Restocked After High Demand and Now Available in Fresh, Timeless Shades

Lumberton, New Jersey – Pure Parima, the leader in luxury Egyptian cotton bedding, is proud to announce the expansion of its highly sought-after Ultra Percale Collection with two elegant new colors: Flax and Salt. Known for its crisp, breathable feel and cooling properties, this collection consistently sells out due to its exceptional quality and hotel-like luxury. Now fully back in stock, customers can once again experience the perfect blend of sophistication and comfort in these fresh, neutral tones.

The Ultra Percale Sheet Set, part of Pure Parima’s Hotel Collection, is designed to bring a sense of calm and refinement to any bedroom. With its elegant matte finish, exceptionally crisp texture, and superior breathability, this collection delivers the ultimate in cooling comfort for those who prefer a fresh, airy sleep experience. Crafted from extra-long, hand-picked Egyptian cotton fibers, these sheets are celebrated for their timeless appeal and durability, making them a staple for those who appreciate luxury bedding.

“The Ultra Percale Collection has remained one of our most in-demand offerings, consistently selling out due to its unmatched quality and feel,” said Parima Ijaz, founder of Pure Parima. “We are excited to bring it back in stock and introduce Flax and Salt, two classic shades that elevate any bedroom aesthetic while delivering the same crisp, cooling comfort our customers love.”

The Ultra Percale Collection in Flax and Salt is available now at www.pureparima.com. Customers are encouraged to shop early before it sells out again.

About Pure Parima

Pure Parima only purchases Egyptian cotton from certified growers, ensuring their product is the best option on the market. They are CEA certified, receiving this certification means their cotton is DNA tested to ensure authenticity. Consumers don’t have to read the fine print with Pure Parima, transparency and truth are their foundation.

Media Contact
Company Name: Otter PR
Contact Person: Gabrielle Lask
Email: Send Email
City: Orlando
State: Florida
Country: United States
Website: OtterPR.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Pure Parima Expands Best-Selling Ultra Percale Collection with Two New Colors: Flax & Salt

Art Institution Founded by Italian Prince Hosts Ruffo Caselli Retrospective: “Cybernetic Existentialism”

Exploring the Intersection of Art, Humanity, and Artificial Intelligence.

Before artificial intelligence became a global force, there was Cybernetic Existentialism — a pioneering artistic vision that explored the convergence of human consciousness and technology. A grand retrospective honoring Ruffo Caselli (Florence, 1932 – Ovada, 2020), one of the earliest artists to incorporate AI themes into his work, will open on March 1, 2025, at the Società Promotrice di Belle Arti Liguria in Genoa, Italy.

This esteemed gallery, founded in 1849 by Prince Carlo Alberto of Savoy, has historically welcomed European royalty, aristocracy, and luminaries of the arts, including the noble Spinola, Pallavicini, and Doria-Pamphili families, as well as the renowned composer Giuseppe Verdi. Today, under the leadership of Dr. Mario Moneta, a distinguished collector and philanthropist, the institution continues its mission of promoting significant artistic contributions.

A Visionary Artist Ahead of His Time

Ruffo Caselli was a trailblazer in integrating themes of artificial intelligence into fine art. His signature style, depicting human-machine hybrids and cybernetic landscapes, raises fundamental questions: Are machines merely tools, or do they represent a new form of existence? Can robotics reflect human emotion, or do they distance us from our own humanity?

Caselli’s paintings offer a contemplative space where technology and emotion intersect. His iconic humanoid figures, marked by geometric precision and enigmatic dots—often interpreted as electronic circuits—suggest a delicate tension between the organic and the mechanical. His thought-provoking work continues to gain recognition among AI scholars and futurists, highlighting the philosophical and ethical dilemmas posed by rapid technological advancements.

The Cybernetic Existentialism retrospective follows recent exhibitions of Caselli’s work in Milan and across Russia, where audiences engaged deeply with his exploration of artificial intelligence, robotics, and human identity.

Expert Perspectives on Caselli’s Legacy

As part of this exhibition, art curator Carmen Gallo has gathered expert commentary from distinguished professionals in the field, who are also collectors of Caselli’s artwork.

Dongxu Zhou, AI Engineer & Researcher (Airbnb, Moveworks, Sierra AI, San Francisco, California), reflects:

“Ruffo Caselli’s work resonates deeply in an era where artificial intelligence is redefining humanity’s trajectory. His vision, manifest in his human-machine hybrids and cybernetic landscapes, anticipated not only the tools we use but also the existential dilemmas we now face. Beyond its aesthetic brilliance, Caselli’s work offers a framework for navigating the ethical and societal challenges posed by advancing technology. As we integrate AI into every aspect of life, his art reminds us to question the trade-offs between efficiency and humanity, between innovation and individuality.”

Dongxu ZhouAI Engineer & Researcher, Airbnb, Moveworks, Sierra AI San Francisco, California with his daughter Aida.

Cora Repetti, Engineer & Release Manager at Zoox (Amazon, San Francisco, California), adds:

“Now that artificial intelligence permeates nearly every aspect of our lives, Ruffo Caselli’s art takes on new meaning. His work envisioned a future that is no longer theoretical—it is here. The figures in his paintings, marked by distinct dots, evoke the electronic chips that now replace human decision-making in autonomous systems. Having spent years working on self-driving cars, I see a profound connection between Caselli’s vision and today’s reality. I wish I could take him on a ride in a robot-taxi—I wonder what he would have thought!”

Engineer Cora Repetti, Release Manager at Zoox (Amazon) San Francisco, California.

Exhibition Details

Cybernetic Existentialism: The Art of Ruffo Caselli will be on display at the Società Promotrice di Belle Arti Liguria, located at Via degli Archi, 39, Genoa, Italy.

For further information, visit www.cyberneticexistentialism.com.

Media Contact
Company Name: Promotrice Belle Arti Liguria
Contact Person: Promotrice Belle Arti
Email: Send Email
Address:Via Degli Archi, 39
State: Genova
Country: Italy
Website: www.cyberneticexistentialism.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Art Institution Founded by Italian Prince Hosts Ruffo Caselli Retrospective: “Cybernetic Existentialism”

BizOp.org Revolutionizes Small Business Buying and Selling with Enhanced Marketplace Features

BizOp.org, a leading platform connecting entrepreneurs with business opportunities, has introduced enhanced features designed to streamline the process of buying and selling small businesses. With a user-friendly interface, advanced search tools, and industry-specific insights, the platform simplifies transactions for business buyers and sellers alike.

As the demand for small business ownership continues to rise, BizOp.org offers a centralized hub where entrepreneurs can explore opportunities, conduct due diligence, and connect with verified sellers. The platform caters to aspiring business owners looking to buy a small business as well as seasoned entrepreneurs seeking to sell a small business in a secure and efficient marketplace.

A One-Stop Solution for Business Transactions

BizOp.org’s latest updates provide a seamless experience for both buyers and sellers. Key features include:

  • Comprehensive Listings: An extensive database of small businesses across various industries, ensuring buyers find the right opportunity.

  • Advanced Search and Filtering: Customizable search options based on location, industry, price range, and profitability.

  • Secure Communication Tools: Direct messaging and negotiation features to facilitate transparent discussions between buyers and sellers.

  • Business Valuation Insights: Resources and expert insights to help sellers price their businesses competitively and attract serious buyers.

Empowering Small Business Owners

The platform serves as a valuable resource for entrepreneurs at every stage of their business journey. Whether looking to invest in an existing venture or transition out of business ownership, BizOp.org offers the necessary tools to make informed decisions. The platform not only simplifies transactions but also provides guidance on legal and financial considerations associated with buying and selling a small business.

Why Entrepreneurs Choose BizOp.org

With a strong reputation for connecting business buyers and sellers efficiently, BizOp.org stands out as a trusted marketplace. The platform’s robust security measures ensure that all listings and transactions are verified, minimizing risks for both parties. Its data-driven approach also helps potential buyers evaluate business performance metrics before making investment decisions.

By continuously evolving and refining its offerings, BizOp.org remains at the forefront of business acquisitions and sales. Entrepreneurs looking to explore opportunities, whether to buy a small business or sell a small business, can visit BizOp.org for more information.

About BizOp.org

BizOp.org is a premier online platform dedicated to connecting entrepreneurs with business opportunities. Specializing in small business transactions, the platform provides a secure, efficient, and resource-rich environment for business buyers and sellers.

Media Contact
Company Name: BizOp
Email: Send Email
Country: United States
Website: https://BizOp.org

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: BizOp.org Revolutionizes Small Business Buying and Selling with Enhanced Marketplace Features

Rolando’s HVAC Offers Comprehensive Heating Services to Tampa Bay Homeowners

“Rolando’s HVAC Offers Comprehensive Heating Services to Tampa Bay Homeowners”
Rolando’s HVAC offers heating repairs, installations, and maintenance to improve system functionality and performance during Florida’s cooler months.

Tampa, FL – As cooler weather settles in across Tampa, Rolando’s HVAC offers heating services for Tampa Bay homeowners, including maintenance, repair, and installation of heating systems such as furnaces, boilers, and heat pumps. By incorporating modern technologies like smart thermostat integration and geothermal heating options, the company helps homeowners manage energy use and maintain comfortable indoor temperatures. These services are tailored to address the needs of Florida’s cooler months.

Expertise in Heating Systems and Beyond

With years of experience in heating system maintenance, repair, and installation, Rolando’s HVAC brings a wealth of expertise to its work. Their trained technicians specialize in servicing various systems, including furnaces, boilers, and heat pumps, which are critical for maintaining energy efficiency and comfort. The company also provides advanced options such as thermostat installations and geothermal heating solutions, offering modern tools for homeowners to enhance their indoor climate control.

“Our team is dedicated to providing services that address the unique needs of Tampa Bay homeowners,” said Rolando Mojarrieta, owner of Rolando’s HVAC. “We aim to deliver practical solutions that improve comfort and energy efficiency in every home we serve.”

Customer feedback reflects the company’s commitment to excellence. Orson I., a recent customer, shared, “Great work done on installing a new AC compressor and furnace. Completed everything in a little less than 4 hours. Well done!” Testimonials like this highlight Rolando’s HVAC’s focus on delivering efficient and high-quality service.

Emergency Repair Services

Rolando’s HVAC offers responsive emergency repair services designed to address heating system issues quickly and effectively. With a 24/7 call center, homeowners can reach out for assistance at any time, ensuring their concerns are addressed promptly. The HVAC company prioritizes flexible scheduling and same-day repair options whenever possible, helping minimize disruptions caused by heating system breakdowns.

By combining professional expertise, efficient scheduling, and a focus on timely service, Rolando’s HVAC provides homeowners with dependable support for urgent heating system repairs. Whether addressing issues with a furnace, boiler, or heat pump, their aim is to get the system up and running quickly to maintain indoor comfort.

Maintenance Programs

In addition to repairs and installations, Rolando’s HVAC emphasizes the importance of regular system maintenance. Maintenance programs include routine inspections, HVAC tune-ups, and duct cleaning, all of which contribute to extending equipment lifespan and improving system efficiency. These services are particularly beneficial for homes with older heating systems or recurring HVAC issues. Homeowners are encouraged to schedule maintenance ahead of seasonal changes to prepare for fluctuating weather conditions.

Industry Expertise and Trusted Brands

Rolando’s HVAC works with trusted manufacturers, including Daikin, Goodman, Lennox and Trane, to deliver high-quality installations and repairs. Their technicians are trained to work with a variety of heating systems, including electric furnaces and oil-based units, ensuring professional standards are met. By staying informed about advancements in the HVAC industry, the company incorporates modern techniques, such as refrigerant management and mold inspections, into its offerings.

Affordable Pricing and Financing Options

To make heating services more accessible, Rolando’s HVAC offers competitive pricing alongside flexible financing options. The company provides warranties, discounts, and payment plans to help homeowners manage the financial demands of HVAC repairs or replacements. These programs reflect a commitment to delivering reliable services without imposing unnecessary financial strain.

Service Areas and Accessibility

Rolando’s HVAC serves Tampa Bay and surrounding areas with heating services designed to address local climate needs. The company also extends its expertise to parts of Florida, from Jacksonville to Miami, offering a broad range of heating and cooling solutions to homeowners in multiple regions.

For more information or to schedule an appointment, visit their heating services page at https://www.rolandoshvac.com/heating/.

About Rolando’s HVAC

Based in the Tampa Bay Area, Rolando’s HVAC is a family-owned company specializing in heating, air conditioning, and plumbing services. Serving homeowners across Florida, from Jacksonville to Miami, the company provides installation, maintenance, and repair solutions for furnaces, boilers, heat pumps, air conditioners, and more. Rolando’s HVAC delivers reliable, energy-efficient solutions tailored to customer needs in the Tampa Bay Area, supported by trained technicians and partnerships with leading manufacturers. The company also offers flexible financing options, maintenance plans, and responsive service to help homeowners maintain year-round comfort.

For more information or to schedule a service, call (813) 373-6804, or visit https://www.rolandoshvac.com.

Media Contact
Company Name: Rolando’s H.V.A.C., LLC
Contact Person: Rolando Mojarrieta
Email: Send Email
Phone: (813) 373 6804
Address:5117 W Rio Vista Ave
City: Tampa
State: FL, 33634
Country: United States
Website: https://www.rolandoshvac.com/tampa/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Rolando’s HVAC Offers Comprehensive Heating Services to Tampa Bay Homeowners

Genotyping Assay Market worth $37.1 billion by 2029

“The global market spans North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. North America leads, supported by widespread adoption of advanced genotyping assay products, government funding for research, growing pharmacogenomics applications, investments in DNA-based testing, adoption of NGS, and presence of key market players.”
The major players in this market are Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Danaher Corporation (US), QIAGEN (Netherlands), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US)

The global genotyping assay market, valued at US$17.4 billion in 2023, is forecasted to grow at a robust CAGR of 13.8%, reaching US$19.4 billion in 2024 and an impressive US$37.1 billion by 2029. This growth is driven by advancements in DNA sequencing technology, rising prevalence of genetic disorders, and increased application in personalized medicine and drug development. Key market drivers include the growing use of genotyping in drug discovery and development, while high instrument costs act as a restraint. Opportunities lie in expanding applications in animal genetics and agricultural biotechnology. North America dominates the market, and major players include Thermo Fisher Scientific, Illumina, and QIAGEN. The market is segmented by product & services, technology, applications, end-users, and regions. Reagents & kits and PCR technologies lead in market share, with pharmacogenomics being the largest application segment.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595

Browse in-depth TOC on “Genotyping Assay Market“

444 – Tables59 – Figures388 – Pages

“Reagents & Kits segment accounted for the highest CAGR”

By product & service, the market is primarily segmented into reagents and kits, instruments, GENOTYPING ASSAY services, and bioinformatics. The reagents & kits segment accounted for the largest share of the Genotyping assay in 2023. The significant portion of this market can be ascribed to the availability of a broad variety of reagents, the rising demand for reagents as a result of the global increase in GENOTYPING ASSAY test volumes, and the comparatively lower initial investment needed to implement reagents and kits for GENOTYPING Assay in pharmacies and diagnostic facilities.

“The polymerase chain reaction (PCR) segment accounted for the market share in the genotyping assay market, by technology, during the forecast period”

By technology, the market is primarily segmented into polymerase chain reaction (PCR), microarrays, capillary electrophoresis, sequencing, matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF), and other technologies (in situ hybridization and allele-specific oligonucleotides). The PCR segment accounted for the largest share of the GENOTYPING ASSAY technology market in 2023. The main factors propelling the growth of the PCR market are the introduction of new technologies like reverse transcriptase PCR, nested PCR, hot-start PCR, allele-specific PCR, and multiplex PCR; technological developments in PCR instruments and reagents; and the growing use of PCR technologies in the domains of genetics, prenatal testing, forensics, and personalized medicine.

“Pharmacogenomics segment accounted for the highest share”

By application, the market is primarily segmented into pharmacogenomics, diagnostics & personalized medicine, agricultural biotechnology, animal genetics, and other applications. The pharmacogenomics segment accounted for the largest share of the GENOTYPING ASSAY applications market in 2023. The need to lower the overall cost of medication development for pharmaceutical companies and the growing demand for pharmacogenomics to research adverse drug reactions (ADRs) in clinical trials are the primary drivers of growth in this market. The pharmacogenomics genetyping test is predicted to grow due to various factors, including the rising need for personalized medication, the rise in hereditary and life-threatening disorders, and ongoing research on effective and alternative drug delivery techniques.

“Biopharmaceutical & pharmaceutical companies segment accounted for the highest share”

By end user, the market is primarily segmented into biopharmaceutical & pharmaceutical companies, diagnostic laboratories, academic & research institutes, and other end users. The biopharmaceutical & pharmaceutical companies segment accounted for the largest share of the GENOTYPING ASSAY end-user market in 2023. The significant market share of this industry may be ascribed to the growing need for pharmacogenomics in the drug research and discovery process, the introduction of new products, and FDA recommendations to incorporate pharmacogenomics studies and GENOTYPING ASSAY in the drug discovery process. Furthermore, growing partnerships and funding for pharmacogenomics research further support the expansion of this market sector for GENOTYPING ASSAY.

“North America aimed for the largest share of the genotyping assay market”.

The global genotyping assay market is segmented into six major regions—North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa and GCC Countries. North America is the largest regional market for genotyping assays. North America is the largest regional market for cancer biomarkers. This regional segment’s dominance can be attributed to a number of factors, including the growing use of technologically sophisticated GENOTYPING ASSAY products, the availability of government and private funding for research projects based on GENOTYPING ASSAY, the expanding use of GENOTYPING ASSAY in pharmacogenomics, rising investments in DNA-based testing, the growing uptake of NGS, and the presence of major market players in the area.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595

The major players in this market are Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Danaher Corporation (US), QIAGEN (Netherlands), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Merck KGAA (Germany), Agilent Technologies (US), Revvity Inc. (US), Standard Bio Tools (US), PacBio (US), GENEWIZ Inc. (US), Luminex Corporation (Diasorin Company) (US), Oxford Nanopore Technologies Plc (UK), GenScript (US), Takara Bio Inc. (Japan), New England Biolabs (US), Promega Corporation (US), Tecan Trading AG (Switzerland), Genotypic Technology Pvt. Ltd. (India), BGI GROUP (China), Novogene Co., Ltd. (China), Paragon Genomics, Inc. (US), NeoGenomics Laboratories (US).

Thermo Fisher Scientific Inc. (US)

Thermo Fisher held the leading position in the genotyping assay market in 2023. The players’s top position in this market is primarily due to its vast products range, which includes genomic profiling, PCR, microarray analysis, instruments and kits & reagents. Also, the company has a quite huge hold in terms of geographical presence which covers North America, Europe, Latin America, the Middle East, the Asia Pacific and Africa,. To maintain its top rank in the market, the company is always determined in launching new products and partnering and collaborating with other players existent in this market.

Illumina, Inc. (US)

Illumina grabbed the second position in the genotyping market in 2023. The company has been in lead with its flagship NGS platforms in the sequencing market. Reagents such as TruSeq sample preparation kits, TruSeq SBS sequencing kits, and various other sequencing reagents are provided by the company, along with services which include whole genome sequencing, human whole exome sequencing, de novo sequencing, custom-targeted resequencing, gene expression using random-primed RNA sampling, and others. To maintain its position in the market, the player is signing numerous agreements, partnerships with small scale players and launching new and innovative products to build a strong product portfolio.

For more information, inquire now! Inquire Now

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Genotyping Assay Market worth $37.1 billion by 2029

Digicrusader Launches AI Tools Marketplace to Empower Users & Businesses

Launched by Industry Veterans Anurag Jain and Ujala Pandya, Digicrusader Aims to Empower Users and Businesses in the AI Ecosystem

Digicrusader, an innovative AI marketplace designed to help users discover the best AI tools and access cutting-edge AI resources, has been officially launched by Anurag Jain and Ujala Pandya. With over two decades of experience in the digital domain, Jain and Pandya are on a mission to supercharge growth for businesses and individuals through the power of artificial intelligence.

Anurag Jain, a global business leader who has held key positions at Johnson & Johnson, Amazon, Abbott, and Expedia, brings unparalleled expertise to the venture. He is also the bestselling author of “POWERHOUSE: Proven AI Playbook to 10x Your Business and Leadership Impact,” making him a thought leader in the AI space. Together with Ujala Pandya, Jain has created a platform that bridges the gap between AI innovation and real-world application.

What Makes Digicrusader Unique?

1. AI Marketplace for Growth

Digicrusader enables users to discover the best AI tools tailored to their needs. From business automation to creative solutions, the platform curates a wide range of tools to help users achieve their goals faster and more efficiently.

2. Rewards for Engagement

Digicrusader introduces a unique feature where users can earn points by reviewing AI tools. These points can be redeemed for exciting rewards, turning user engagement into tangible benefits.

3. Boost for AI Vendors

Vendors can list and advertise AI Tools on Digicrusader to build visibility and connect directly with their target audience. By tapping into Digicrusader’s growing user base, vendors can enhance their reach and accelerate business growth.

4. Impressive Growth Metrics

Since its launch, Digicrusader has already achieved remarkable traction, boasting over 50% growth in traffic in the last month alone, primarily from USA — a testament to its relevance and value in the AI ecosystem.

A Vision for the Future

“Digicrusader is more than a marketplace; it’s a community-driven platform that empowers users to embrace AI and equips businesses to thrive in the digital age,” said Anurag Jain. “Our goal is to make AI accessible and beneficial to everyone, while fostering collaboration between users and vendors in the AI space,” added Ujala Pandya.

With its innovative features and a strong focus on user and vendor empowerment, Digicrusader is set to become a game-changer in the rapidly evolving AI landscape.

About Digicrusader

Digicrusader is an AI marketplace that enables users to discover top AI tools, access valuable resources, and engage with a unique rewards system for tool reviews. It also provides vendors a platform to showcase their AI tools to a highly targeted audience, helping them grow their businesses.

For more information, visit http://www.digicrusader.comor contact at anurag@digicrusader.com

Media Contact
Company Name: Digicrusader – AI Marketplace and Coach
Contact Person: Anurag Jain
Email: Send Email
Country: United States
Website: https://digicrusader.com/ai-marketplace

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Digicrusader Launches AI Tools Marketplace to Empower Users & Businesses

Infectious Disease Diagnostics Market worth $31.5 billion by 2028

“F. Hoffmann-La Roche Ltd. (Switzerland) held a leading position in the infectious disease diagnostics market. The company has maintained this position in the market through its strong distribution networks across North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa.”
The major players operating in this market are Abbott (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux (France), Siemens Healthineers AG (Germany), Danaher (US), Hologic, Inc. (US)

The global infectious disease diagnostics market in terms of revenue was estimated to be worth $21.4 billion in 2023 and is poised to reach $31.5 billion by 2028, growing at a CAGR of 8.0% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Government initiatives, schemes, or funding that support and promote the innovation and development of the diagnostics market provide growth opportunities in the market. These financial incentives and support systems enable companies/institutes to invest in R&D, infrastructure, and the production of advanced diagnostic technologies. By facilitating access to funds, the manufacturers can push the boundaries of diagnostics, leading to breakthrough innovations in disease detection, monitoring, and personalized medicine.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116764589

Browse in-depth TOC on “Infectious Disease Diagnostics Market”

172 – Tables

53 – Figures

309 – Pages

The reagents, kits, and consumables segment held the largest share of the infectious disease diagnostics market by product & service segment.

The infectious disease diagnostics market is segmented into reagents, kits, and consumables; instruments; and software & services based on product & service. The reagents, kits, and consumables segment dominated the infectious disease diagnostics market in 2022. The requirement of reagents, kits, and consumables in large numbers compared to instruments is the main factor contributing to the large share of this segment. Unlike instruments, reagents, kits, and consumables require repeat purchases, which results in stable demand among end users.

The blood, serum, and plasma segment held the largest share of the infectious disease diagnostics market by sample type segment

Based on sample type, the infectious disease diagnostics market has been segmented into blood, serum, and plasma, urine, and other sample types. In 2022, the blood, serum, and plasma segment accounted for the largest share of the infectious disease diagnostics market, by sample type. These sample types provide a rich and diverse pool of infectious disease diagnostic information. They contain circulating DNA, RNA, proteins, and other biomarkers that carry valuable insights into various diseases and conditions. This wealth of information enables healthcare professionals to make accurate diagnoses, monitor disease progression, and personalize treatment decisions.

North America is the largest regional market for infectious disease diagnostics market.

The market for infectious disease diagnostics has been divided into five key geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the predominant portion of the infectious disease diagnostics market. The infectious disease diagnostics market in North America is well-established, with the US being a major market in this region. This dominance can be attributed to various factors, including advanced healthcare infrastructure, a high prevalence of infectious diseases, and significant investments in diagnostic technologies.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589

The break-up of the profile of primary participants in the infectious disease diagnostics market:

  • By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
  • By Designation: C-level – 27%, D-level – 18%, and Others – 55%
  • By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and Middle East & Africa- 4%

Key Market Players of Infectious Disease Diagnostics Industry:

The major players operating in this market are Abbott (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux (France), Siemens Healthineers AG (Germany), Danaher (US), Hologic, Inc. (US), Becton, Dickinson and Company (US), Revvity (US), QIAGEN (Netherlands), Seegene Inc. (South Korea), Grifols, S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), QuidelOrtho Corporation (US), Meridian Bioscience (US), Genetic Signatures Ltd. (Australia), OraSure Technologies (US), Trinity Biotech (Ireland), Chembio Diagnostics, Inc. (US), Co-Diagnostics, Inc. (US), ELITech Group (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), Vela Diagnostics (Singapore), and Uniogen Oy (Finland).

F. Hoffmann-La Roche Ltd. (Switzerland) held a leading position in the infectious disease diagnostics market. The company has maintained this position in the market through its strong distribution networks across North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Roche has a strong direct and indirect distribution network globally, which helps insulate its business from demand fluctuations in various geographies. The company adopts inorganic growth strategies to increase its dominance in this market. The company focuses on strategies, such as partnerships and acquisitions, to garner a larger market share. In November 2021, the company launched cobas 5800 molecular laboratory instruments used for infectious disease diagnostics.

Abbott (US) held a significant market share in the infectious disease diagnostics market. Its dominant position in this market can be credited to the robust global sales and distribution network, allowing effective product marketing across diverse countries. Additionally, Abbott has heightened its emphasis on research and development endeavors. The company’s substantial investments in R&D, aimed at refining its portfolio and optimizing capital allocation strategies, contribute to its prospective growth and sustained competitiveness in the Diagnostics segment.In addition, Abbott’s strategies, which involve product launches and regulatory approvals, aim to further strengthen its position in the infectious disease diagnostics market. For instance, in March 2021, the company received Emergency Use Authorization (EUA) from the FDA for a laboratory PCR assay, Alinity m Resp-4-Plex molecular assay, that detects and differentiates between SARS-COV-2, flu A, flu B, and RSV in one test.

bioMérieux (France) accounted for the third largest share of the infectious disease diagnostics market. The company has successfully positioned itself as a strong player in the infectious disease diagnostics market. The firm focuses on developing innovative products for infectious disease indications. In May 2022, the company received a CE mark for its VIDAS tests for Chikungunya virus diagnosis.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=116764589

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Infectious Disease Diagnostics Market worth $31.5 billion by 2028

Lantana Recovery Rehab Expands Services to Address Growing Need for Comprehensive Recovery Programs

Lantana Recovery Rehab Expands Services to Address Growing Need for Comprehensive Recovery Programs
Lantana Recovery Rehab, a leading provider of addiction treatment services, has announced an expansion of its programs to serve better individuals seeking long-term recovery in the Charleston area. The initiative aims to enhance access to evidence-based care and focus on outpatient services to accommodate diverse needs.

The expanded offerings come in response to rising concerns about the prevalence of substance use disorders in the region. With a commitment to helping individuals rebuild their lives, Lantana Recovery Rehab provides tailored treatment plans that prioritize mental health and sustainable recovery pathways. Programs include counseling, group therapy, and family support, ensuring a holistic approach to healing.

Recognized as a trusted resource for Drug Rehab Charleston, Lantana Recovery Rehab combines clinical expertise with compassionate care. By leveraging innovative therapies and community resources, the center addresses the root causes of addiction and empowers individuals to regain control of their lives.

For those seeking flexibility, the center’s Outpatient Rehab Charleston services have been praised for their accessibility and personalized approach. Outpatient care allows participants to maintain work, school, and family responsibilities while receiving the support they need to overcome addiction. The programs are designed to accommodate different lifestyles while focusing on long-term success.

Additionally, Lantana Recovery Rehab emphasizes the importance of specialized care for alcohol dependency. Its comprehensive Alcohol Rehab Charleston program addresses the unique challenges associated with alcohol use disorders, offering detox support, relapse prevention strategies, and ongoing counseling. The center’s commitment to individualized treatment ensures every client receives care tailored to their needs.

About Lantana Recovery Rehab:

“Lantana Recovery Rehab is dedicated to meeting the growing demand for effective treatment options,” said a representative. “By expanding our services, we’re ensuring that individuals in Charleston have the resources they need to pursue a healthier future.”For more information about Lantana Recovery Rehab’s programs, visit their website or contact (843) 281-7964.

Media Contact
Company Name: Lantana Recovery Rehab
Contact Person: Lauren Carver
Email: Send Email
Phone: (843) 281-7964
Address:65 Gadsden St
City: Charleston
State: SC
Country: United States
Website: https://lantanarecovery.com/addiction-services-near-me/outpatient-rehab-charleston-south-carolina/

Israel Data Center Market Investment to Reach $1.39 Billion by 2030 – More than 89 MW Power Capacity to be Added in the Next 6 Years – Arizton

“Israel Data Center Market Research Report by Arizton”

    

According to Arizton’s latest research report, the Israel data center market is growing at a CAGR of 13.23% during 2024-2030.

 

Looking for More Information? Click: https://www.arizton.com/market-reports/israel-data-center-market

 

Report Scope:     

Market Size -Investment (2030): $1.39 Billion

Market Size – Area (2030): 371 Thousand Sq. Ft

Market Size – Power Capacity (2030): 89 MW

CAGR -Investment (2024-2030): 13.23% 

Colocation Market Size – Revenue (2030): $295 Million

Historic Year: 2021-2023            

Base Year: 2024           

Forecast Year: 2025-2030             

 

The Israel data center market is experiencing significant growth. Government initiatives like the Digital Israel project are fueling this growth, providing grants, tax exemptions, and financial incentives to attract both local and international investors. Key players include local operators such as MedOne, Bezeq International, and Bynet Data Communications, along with global giants like AWS, Microsoft, and Oracle. New entrants like Techtonic and NED are also making major investments to expand their operations in Israel. Cloud providers have established dedicated regions in strategic locations like Tel Aviv and Jerusalem, enhancing Israel’s position in the global cloud ecosystem. Notably, Salesforce’s introduction of its Hyperforce platform in Israel and MedOne’s $270 million investment in underground data centers reflect the country’s growing appeal for secure, scalable digital infrastructure. Despite geopolitical tensions, the Israel data center sector remains robust, with major developments continuing to shape its future.

 

Growth and Investment in Israel’s Data Center Market

Israel’s data center market is expanding, with key investment locations in Tel Aviv, Petah Tikva, and emerging cities like Jerusalem and Rosh Haayin. Business-friendly zones such as the Tel Aviv Metropolitan Area and Haifa Bay offer incentives for foreign investors, attracting high-tech and logistics companies. Industrial rents in high-demand areas range from $15 to $20 per square foot, while more affordable zones like Haifa Bay offer rates between $10 to $14.

Notable upcoming developments include MedOne’s underground data centers in Kfar Yona, Keystone’s facilities in Be’er Tuvia, and new projects by NVIDIA, Techtonic, and NED. These investments highlight the growing demand for data center space in Israel.

 

Israel Smart City Developments and Data Center Integration

Israel is leading the charge in smart city development, integrating technologies like IoT, AI, and big data to improve urban living. Cities like Tel Aviv and Haifa are pioneering real-time traffic management, digital services, and energy efficiency. The growing digital economy, fueled by increasing internet penetration and online services, directly impacts the data center market, driving demand for infrastructure to support smart city projects.

Key initiatives like the Digital Israel Initiative and Tel Aviv’s Smart City Lab focus on transforming public services and creating interconnected urban systems. These projects leverage data centers to enable e-governance and optimize resource management. For example, IoT devices in smart cities help monitor and manage electricity and water usage efficiently.

Israel’s data center market is supported by global technology companies such as Google, AWS, and Microsoft, whose platforms host various smart city applications. Additionally, innovations in urban transportation, such as Waze and Mobileye’s autonomous vehicles, rely on data centers for processing real-time traffic data, further enhancing Israel’s smart city landscape. The country’s focus on sustainability, innovation, and advanced infrastructure is attracting international tech investments and shaping its technological and economic future.

 

Data Center Cooling Systems in Israel

Israel data centers utilize advanced cooling technologies to ensure optimal performance and reliability. Most facilities implement CRAC (Computer Room Air Conditioning) units and chiller units with N+1 redundancy, ensuring backup cooling capabilities. Notable examples include Infinity’s Raanana data center, Bezeq International’s state-of-the-art facility, and MedOne’s centers, all featuring N+1 redundant CRAC units and chillers. Larger data centers are adopting more sustainable solutions, such as water-based cooling systems, with companies like Serverfarm incorporating air-cooled chillers and free cooling with CRAH. NED’s Alpha data center is pioneering direct liquid cooling (DLC) for continuous, redundant cooling, while Anan’s Afula data center utilizes highly efficient 2N water-cooled chillers with N+1 CRAH support. These advanced systems are crucial for managing high electricity consumption and ensuring high reliability across Israel’s data center infrastructure.

 

Why Should You Buy this Research?

This research provides a comprehensive overview of Israel’s data center market, offering insights into the investment, growth trends, and key players in the sector. Key highlights include:

Market Size and Revenue: In-depth analysis of the investment, area, power capacity, and colocation market revenue in Israel.

  • Data Center Investments: Assessment of investments from colocation, hyperscale, and enterprise operators, including data center space (sq. ft.) and power capacity (MW) across major cities.
  • Current Market Landscape: Detailed study of existing data centers, along with predictions for future growth.
  • Facilities Coverage: 28 existing facilities and 27 upcoming facilities across 10+ cities.
  • Colocation Market: Revenue forecasts (2021-2030) for colocation services, including wholesale vs. retail and pricing trends.
  • Investment Breakdown: Classification of market investments by IT, power, cooling, and construction services, with sizing and forecasts.
  • Market Trends: Insight into the latest trends, growth opportunities, challenges, and industry prospects.
  • Key Players: Business overview and offerings of leading IT infrastructure providers, contractors, and investors.
  • Research Methodology: Transparent methodology with detailed demand and supply analysis.

This research offers crucial data for understanding the potential and future direction of the Israel data center market.

 

Book the Free Sample Now: https://www.arizton.com/market-reports/israel-data-center-market

 

The report includes the investment in the following areas:

 

IT Infrastructure

  • Server Infrastructure
  • Storage Infrastructure
  • Network Infrastructure

 

Electrical Infrastructure

  • UPS Systems
  • Generators
  • Transfer Switches & Switchgears
  • PDUs
  • Other Electrical Infrastructure

 

Mechanical Infrastructure

  • Cooling Systems
  • Rack Cabinets
  • Other Mechanical Infrastructure

 

Cooling Systems

  • CRAC and CRAH Units
  • Chillers Units
  • Cooling Towers, Condensers and Dry Coolers
  • Other Cooling Units

 

General Construction

  • Core & Shell Development
  • Installation & Commissioning Services
  • Building & Engineering Design
  • Fire Detection & Suppression Systems
  • Physical Security
  • Data Center Infrastructure Management (DCIM)

 

Tier Standard

  • Tier I & II
  • Tier III
  • Tier IV

 

Vendor Landscape

 

IT Infrastructure Providers

  • Broadcom
  • Cisco
  • Dell Technologies
  • Fujitsu
  • Hewlett Packard Enterprise
  • Hitachi Vantara
  • IBM
  • Lenovo
  • NetApp

 

Data Center Construction Contractors & Sub-Contractors

  • Ashtrom Group
  • Auerbach Halevy Architects
  • Electra Group
  • M+W Group
  • Mercury
  • Margolin Bros. Engineering & Consulting
  • MiCiM
  • Saan Zahav
  • Skorka Architects
  • Yeda Engineering

 

Support Infrastructure Providers

  • ABB
  • Caterpillar
  • Cummins
  • Delta Electronics
  • Eaton
  • ETAP
  • HITEC Power Protection
  • Johnson Controls
  • Keysight Technologies
  • Legrand
  • Mitsubishi Electric
  • Rittal
  • Rolls-Royce
  • Schneider Electric
  • Siemens
  • STULZ
  • Vertiv

 

Data Center Investors

  • Adgar Investments & Development
  • Amazon Web Services
  • Bezeq International
  • Bynet Data Communications
  • Compass Datacenters
  • EdgeConneX
  • Global Technical Realty
  • MedOne
  • Microsoft
  • Oracle
  • Serverfarm

 

New Entrants

  • Anan
  • Mega Data Centers
  • MultiDC – Data Center Campus
  • NED
  • Serverz Data Center
  • Techtonic

 

Key Questions Answered in the Report:     

How big is the Israel data center market?

What factors are driving the Israel data center market?

What is the growth rate of the Israel data center market?

How much MW of power capacity will be added across Israel during 2025-2030?

 

Why Arizton?                                              

100% Customer Satisfaction                                              

24×7 availability – we are always there when you need us                                              

200+ Fortune 500 Companies trust Arizton’s report                                              

80% of our reports are exclusive and first in the industry                                              

100% more data and analysis                                              

1500+ reports published till date                            

                 

Post-Purchase Benefit                                          

  • 1hr of free analyst discussion                                          
  • 10% off on customization                       

           

About Us:                                                                                   

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services. 

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts. 

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports. 

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/israel-data-center-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Israel Data Center Market Investment to Reach $1.39 Billion by 2030 – More than 89 MW Power Capacity to be Added in the Next 6 Years – Arizton

Drug Screening Market worth $19.5 billion by 2029

“Prominent players offering drug screening products and services include Labcorp (US), Quest Diagnostics (US), Abbott (US), Thermo Fisher Scientific Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies Inc. (US), Siemens Healthineers AG (Germany)”
Labcorp (US): Labcorp is a leading player in the US drug screening services market that provides clinical laboratory services and drug development solutions. The company operates through two reportable segments—Diagnostics Laboratories (Dx), which includes routine testing and specialty/esoteric testing, and Biopharma Laboratory Services (BLS), consisting of Early Development Research Laboratories and Central Laboratory Services.

The global drug screening market, valued at US$7.7 billion in 2023, is forecasted to grow at a robust CAGR of 16.6%, reaching US$9.1 billion in 2024 and an impressive US$19.5 billion by 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Some of the key factors such as the enforcement of stringent laws mandating drug & alcohol testing, the rising drug & alcohol consumption are driving the market. However, bans on alcohol consumption in Islamic countries may restrain the growth of this market to a certain extent.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

Browse in-depth TOC on “Drug Screening Market”

740 – Tables62 – Figures533 – Pages

Services segment is expected to grow at the highest CAGR during the forecast period in 2024.

On the basis of product & service segment, the drug screening market is bifurcated into services and products. In 2023, the services segment accounted for the largest share of the drug screening market. Factors such as rising global drug and alcohol consumption, funding schemes for drug testing laboratories, and rising regulatory approvals for drug products & services, and geographic extensions of drug & alcohol testing laboratories.

Analytical instruments are projected to dominate the drug screening products market in 2023, by product.

On the basis of drug screening product, the drug screening market is bifurcated into analytical instruments, rapid testing devices, and consumables. The analytical instruments are expected to dominate the market in 2023. However, the rapid testing devices segment is expected to register the highest CAGR during the forecast period, owing to its recurring requirement. Analytical instruments for drug screening are further categorized into immunoassay analyzers, chromatography instruments, and breathalyzers. The breathalyzers segment accounted for largest share of the drug screening products market, by analytical instruments.

Urine sample segment is accounted for the largest share of the drug screening market in 2023, by sample type.

On the basis of sample type, drug screening market is bifurcated into urine, breath, oral fluid, hair, and other samples. In 2024, the urine sample segment is expected to account for the largest share of drug screening market. Urine tests are widely adopted in drug screening tests due to their accuracy in detecting multiple drug classes. Urine tests are also cost-effective and showcase instant results.

By region, North America to dominate the market for drug screening in 2024

In 2024, North America is projected to dominate the market followed by Europe. Factors such as the increasing consumption of illicit drugs, the increasing burden of accidents due to alcohol impairment, the availability of government funding to curb drug abuse, laws supporting drug screening, and the existence of key players in the region are factors driving the growth of the drug screening market in this region.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type – Tier 1: 57%, Tier 2: 30%, and Tier 3: 13%
  • By Designation – C-level: 30%, D-level: 45%, and Others: 25%
  • By Region – North America: 40%, Europe: 19%, Asia Pacific: 29%, Latin America: 7% and Middle East and Africa: 5%

Key Market Players of Drug Screening Industry:

Prominent players offering drug screening products and services include Labcorp (US), Quest Diagnostics (US), Abbott (US), Thermo Fisher Scientific Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies Inc. (US), Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), MPD Inc. (US), Shimadzu Corporation (Japan), Lifeloc Technologies, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics Corporation (US), Clinical Reference Laboratory, Inc. (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), CareHealth America Corp (US), Sciteck, Inc. (US), Intoximeters, Inc. (US), AccuSourceHR, Inc. (US), Cordant Health Solutions (US), Intoxalock (US), Millennium Health (US).

Labcorp (US): Labcorp is a leading player in the US drug screening services market that provides clinical laboratory services and drug development solutions. The company operates through two reportable segments—Diagnostics Laboratories (Dx), which includes routine testing and specialty/esoteric testing, and Biopharma Laboratory Services (BLS), consisting of Early Development Research Laboratories and Central Laboratory Services. The company’s Diagnostics Laboratories (Dx) segment offers drug and alcohol testing services. The company has more than 67,000 employees serve clients in over 100 countries, worked on over 84% of the new drugs approved by the FDA in 2023 and executed more than 600 million tests for patients around the world. The company has more than 80,000 employees, serves clients in more than 100 countries. Recently, in 2024 Labcorp announces acquisition of select assets of BioReference Health’s diagnostic business expanding access to the company high-quality clinical laboratory services.

Abbott (US): Abbott is one of the global providers of rapid, point of care tests and leader in drug screening market. Abbott operates via five business segments: Established Pharmaceuticals Products, Nutritional Products, Diagnostic Products, & Medical Devices. The Diagnostic products include sales of diagnostic systems tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The company provides drug screening products and services through the diagnostic products segment. The company’s Diagnostics Product is further segmented into Core Laboratory, Rapid Diagnostics, Molecular, and Point of care. The company has a strong presence in North America, Europe, Asia Pacific, Latin America, & Middle East & Africa. The company provide substance abuse testing products and services for a array of settings such as rehabilitation centers,hospitals, criminal justice agencies, physician offices, workplace, and occupational health clinics, and homes.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162987773

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/drug-alcohol-screening-market-162987773.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Drug Screening Market worth $19.5 billion by 2029